These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
25. Effects of anti-IL 2 receptor monoclonal antibody and cyclosporine on IL 2 receptor-positive cells infiltrating cardiac allografts in the rat. Lord RH; Hancock WW; Colby AJ; Padberg W; Diamantstein T; Kupiec-Weglinski JW; Tilney NL Transplant Proc; 1987 Feb; 19(1 Pt 1):354-5. PubMed ID: 3079156 [No Abstract] [Full Text] [Related]
26. Prolonged survival of guinea pig-to-rat heart xenografts using repeated low doses of cobra venom factor. Tavakoli R; Michel A; Cardoso J; Ayani E; Maillet F; Fontaliran F; Crougneau S; Weill B; Houssin D Transplant Proc; 1993 Feb; 25(1 Pt 1):407-9. PubMed ID: 8438356 [No Abstract] [Full Text] [Related]
27. From ginkgolides to N-substituted piperidino-thieno diazepines, a new series of highly potent dual antagonists. Braquet P; Laurent JP; Rolland A; Martin C; Pommier J; Hosford D; Esanu A Adv Prostaglandin Thromboxane Leukot Res; 1991; 21B():929-37. PubMed ID: 1825436 [No Abstract] [Full Text] [Related]
28. Changes in cytosolic free calcium induced by platelet-activating factor in rabbit platelets: specific inhibition by BN 52021 and structurally related compounds. Baroggi N; Etienne A; Braquet P Agents Actions Suppl; 1986; 20():87-97. PubMed ID: 3028108 [TBL] [Abstract][Full Text] [Related]
30. The effect of the platelet-activating factor antagonist, BN 52021, on human natural killer cell-mediated cytotoxicity. Mandi Y; Farkas G; Koltai M; Beladi I; Mencia-Huerta JM; Braquet P Immunology; 1989 Jul; 67(3):370-4. PubMed ID: 2759659 [TBL] [Abstract][Full Text] [Related]
31. Prolongation of cardiac allograft survival following intraportal injection of donor antigen is inhibited by cyclosporine A. Farges O; Buffello D; Shi YM; Moufetier A; Bismuth H Transplant Proc; 1995 Aug; 27(4):2525-7. PubMed ID: 7652915 [No Abstract] [Full Text] [Related]
32. Immunosuppressive effects of leflunomide in a cardiac allograft model. Williams JW; Xiao F; Foster PF; Chong A; Sharma S; Bartlett R; Sankary HN Transplant Proc; 1993 Feb; 25(1 Pt 1):745-6. PubMed ID: 8438465 [No Abstract] [Full Text] [Related]
33. A platelet-activating factor antagonist reduces corneal allograft inflammation and neovascularization. Cohen RA; Gebhardt BM; Bazan NG Curr Eye Res; 1994 Feb; 13(2):139-44. PubMed ID: 8194360 [TBL] [Abstract][Full Text] [Related]